A niche CDMO, with specialized technologies in complex injectable development, will have greater flexibility for successful manufacture of complex injectables in early phase development of therapeutic drugs.
The issues associated with amorphous formulations include solid state stability, chemical stability, reproducibility of API manufacturing, impurity of API, in vitro in vivo performance, process and scale-up.
With the increasing percentage of water-insoluble or low permeable new therapeutic entities among drug pipelines, lipid-based drug delivery systems have become an important tool for formulation development.
Liposome technology is an effective drug delivery tool but still presents difficulties. Learn about how developers are meeting these challenges and the opportunities for advancement to maximize liposome usefulness.
Challenges specific to eye physiology complicate the development of new therapies and necessitate innovative drug delivery methods. Examine the potential of new biodegradable polymers for successful drug delivery.
Additive manufacturing, or 3D printing, is arguably balancing on the cusp of translation from academic research into industry practice for pharmaceuticals. What will the future impact of 3D printing be?